Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy
Open Access
- 17 May 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (5) , 677
Abstract
Due to variability in pharmacokinetics and pharmacodynamics, clinical outcomes of antimicrobial drug therapy vary between patients. As such, personalised medication management, considering both pharmacokinetics and pharmacodynamics, is a growing concept of interest in the field of infectious diseases. Therapeutic drug monitoring is used to adjust and individualise drug regimens until predefined pharmacokinetic exposure targets are achieved. Minimum inhibitory concentration (drug susceptibility) is the best available pharmacodynamic parameter but is associated with many limitations. Identification of other pharmacodynamic parameters is necessary. Repurposing diagnostic biomarkers as pharmacodynamic parameters to evaluate treatment response is attractive. When combined with therapeutic drug monitoring, it could facilitate making more informed dosing decisions. We believe the approach has potential and justifies further research.Keywords
This publication has 107 references indexed in Scilit:
- Nanobiosensors for procalcitonin (PCT) analysisJournal of Clinical Laboratory Analysis, 2024
- Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel DiseaseCurrent Gastroenterology Reports, 2023
- Antifungal stewardship in critically ill patientsIntensive Care Medicine, 2023
- (1 → 3)-β-d-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trialIntensive Care Medicine, 2022
- From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for AntibioticsClinical Pharmacology & Therapeutics, 2021
- Real‐World Infliximab Pharmacokinetic Study Informs an Electronic Health Record‐Embedded Dashboard to Guide Precision Dosing in Children with Crohn’s DiseaseClinical Pharmacology & Therapeutics, 2020
- ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patientsIntensive Care Medicine, 2019
- Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysisReviews in Medical Virology, 2019
- Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trialIntensive Care Medicine, 2017
- The natural elimination rate of procalcitonin in patients with normal and impaired renal functionIntensive Care Medicine, 2000